Latest News

All the news from Anaphylaxis UK

Looking for Allergy Alerts?

Allergy Alerts

Latest News from Anaphylaxis UK

Introducing allergens during weaning 21st May 2025

Last week Anaphylaxis UK celebrated National Weaning Week 2025—a time dedicated to supporting families as they introduce solid foods to their babies. We marked the occasion by publishing a podcast, offering practical, evidence-based information on safely introducing common allergens during
[…]

Read more
That finish line feeling 14th May 2025

Huge congratulations to our half marathon and marathon runners who proudly represented Anaphylaxis UK in April across the country (and internationally!). We were so lucky to have a passionate and committed team, and we’re in absolute awe of everyone’s dedication
[…]

Read more
Safeguarding in the early years: important changes coming in September 2025  13th May 2025

Early years providers, including those offering PVI (Private, Voluntary, and Independent) wraparound care, need to be aware of significant upcoming changes to safeguarding practices.  The changes being made to safeguarding are mandatory and will be included in inspections from 1st
[…]

Read more

News Type:

MHRA issues important alert for Emerade 300mcg and 500mcg auto injectors 7th April 2020

7th April 2020 This is a different alert to that issued on 04 March 2020 for Emerade 150 microgram auto-injectors. The UK’s regulator of medicines (Medicines & Healthcare products Regulatory Agency [MHRA]) has received updated information from the company that

Read more
COVID-19 & takeaways: advice issued on allergy safety 3rd April 2020

On the 23rd March 2020 the government announced that all restaurants, pubs and cafés would have to close as part of measures to combat the spread of the novel coronavirus. The government has temporarily relaxed planning rules for these food

Read more
Obituary: Dr. Alfred William Frankland MBE, Honorary President of the Anaphylaxis Campaign 2nd April 2020

The Anaphylaxis Campaign is deeply saddened to learn of the death of its Honorary President, Dr. William Frankland, who died today (2 April 2020) at the age of 108. Throughout his life, Dr. Frankland worked to improve the lives of

Read more
Nutricia Paediatric’s statement on the availability of specialist formula 2nd April 2020

With concerns from the allergic community about the lack of availability of FreeFrom and alternative foods during the coronavirus pandemic, The Anaphylaxis Campaign would like to share the following statement from Nutricia Paediatric regarding the availability of specialist formula: For

Read more
Open Letter to supermarkets on the availability of Freefrom and alternative foods 23rd March 2020

The Anaphylaxis Campaign, the only UK wide charity operating solely for the growing numbers of people at risk from severe allergic reactions and anaphylaxis, has heard increasing concerns from the allergic community about the availability of FreeFrom and alternative foods

Read more
Dr. William Frankland MBE, Honorary President of the Anaphylaxis Campaign, celebrates 108th birthday 19th March 2020

The Anaphylaxis Campaign would like to wish its Honorary President, Dr. William Frankland MBE, a very happy 108th birthday. Throughout his life, Dr. Frankland has worked to improve the lives of others and for more than 50 years, he has

Read more
The Anaphylaxis Campaign and Covid-19 17th March 2020

We have been closely monitoring the developing COVID-19 outbreak and want to reassure you that we are making plans to ensure we can continue to operate as usual and provide our much-needed services and resources to anyone who needs them.

Read more
Statement regarding death of Nicholas Kelly 12th March 2020

We are saddened to learn of the tragic death of Nicholas Kelly, aged 16, due to a suspected allergic reaction, and would like to offer our deepest sympathies to his family at this difficult time. We have very little detail

Read more
MHRA issues important alert for Emerade 150/300/500mcg auto-injectors 4th March 2020

4th March 2020 The UK’s regulator of medicines (Medicines & Healthcare products Regulatory Agency [MHRA]) has received updated information from the company that makes Emerade pens about the defect previously reported by the MHRA. The defect means some pens may

Read more